DSGN vs ORCL · $214.0M cap vs P/E 31, rev $67.36B
Design Therapeutics Inc (DSGN) versus Oracle Corporation (ORCL) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Latest reported DSGN revenue for 2026-06-30 was $0. Net income was -$37.8M. DSGN currently screens at market cap $214.0M.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
DSGN currently screens at market cap $214.0M. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Not investment advice. Open the DSGN and ORCL stock pages for the full models.
Not investment advice.